Skip to main content
. Author manuscript; available in PMC: 2012 Jul 5.
Published in final edited form as: J Proteome Res. 2011 May 11;10(6):2873–2881. doi: 10.1021/pr200200y

Figure 3.

Figure 3

Principal components analysis of metabolic profile differences between patient groups. (A) PCA scores of components 1 and 2 of calculated hydrophilic metabolite levels from control PBSC samples (green) and t-MDS patient PBSC (red). (B) PCA scores of components 1, 2, and 3 for the control PBSC (green) and t-MDS/AML PBSC (red). The explained variances are shown in parentheses.